Improved approach for managing diabetic ketoacidosis (DKA) with DiaSys Hydroxybutyrate 21 FS
DiaSys β-Hydroxybutyrate 21 FS represents a significant advancement in managing diabetic ketoacidosis (DKA), a serious and potentially life-threatening complication of diabetes.


